We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Kronos Bio Inc | NASDAQ:KRON | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.04 | 1.00 | 1.04 | 1.04 | 1.02 | 1.04 | 79,179 | 22:30:02 |
Oral Presentation information
Session Title: Session 4: Medical and Pediatric Oncology and Trials
Presentation Title: A first in-human study of CDK9 inhibitor KB-0742 demonstrates preliminary evidence of clinical activity in transcriptionally addicted sarcomas
Presenter: Brian Van Tine, M.D., of Washington University School of Medicine in St. Louis
Abstract #: 1569811
Date and Time: Thursday November 2, 2023, from 4:00 PM - 5:30 PM IST
To read the press release on the data presented at the AACR-NCI-EORTC International Conference in Boston, Mass. you may visit https://ir.kronosbio.com/news-releases
About Kronos Bio, Inc.
Kronos Bio is a biopharmaceutical company that is advancing two investigational compounds in clinical trials for patients with cancer. The company is developing the CDK9 inhibitor KB-0742 as a treatment for MYC-amplified solid tumors and other transcriptionally addicted solid tumors and lanraplenib, a next-generation SYK inhibitor, for patients with FLT3-mutated acute myeloid leukemia. The company’s scientific focus is on developing medicines that target the deregulated transcription that is the hallmark of cancer and other serious diseases.
Kronos Bio is based in San Mateo, Calif., and has a research facility in Cambridge, Mass. For more information, visit www.kronosbio.com or follow the company on LinkedIn.
Company Contact:Sarah Connors, Vice President of Investor Relations and Corporate CommunicationsKronos Bio857-290-7305sconnors@kronosbio.com
Agency Contact:Brendan Strong, Managing DirectorArgot Partners 212-600-1902kronosbio@argotpartners.com
1 Year Kronos Bio Chart |
1 Month Kronos Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions